I read somewhere that… “if a stock triples in price, sell half your shares.  That takes your money off the table, locks in a nice 50% gain and reduces the risk that one over-weighted stock position could jeopardize your overall wealth.”

Our latest company, Evofem Biosciences, Inc. (Nasdaq: EVFM), has enjoyed a nice run-up from our initial post of $0.34 on 6/2/22 to over a buck today…that’s close to a 300% price increase in less than a month. Everyone has to make their own decisions (and I am not recommending any course of action for any one particular person), but if you follow that thinking, and take your money plus some profits “off the table,” and play with the house’s cash, it’s hard to see fault with that strategy.

The Bottom Line

If it goes to the moon, you get to brag and if it falls completely out of bed, you still get to brag because you locked in some gains…!

That’s just me… you have to decide what’s right for you. Always consult with your trusted financial advisor about your best course of action.

Mike Casson, Publisher/Executive Editor

__________________________________________________________________________

 Disclaimer and Disclosures: MicroCap MarketPlace (MCMP) is a financial publisher and not a FINRA broker/dealer or investment adviser. MCMP is not registered with the SEC / U.S. Securities and Exchange Commission or any state securities regulatory agency. Readers, subscribers and web site visitors are responsible for individual investment decisions. All information contained in our newsletters or on our web site and in our blogs should be independently verified with the featured companies and readers should always conduct their own research and due diligence and engage professional investment advisers as they deem appropriate before making investment decisions. Please review the Terms and Conditions of Use, including without limitation all disclaimers of warranties and limitations on liability contained therein. Your use of any information on our websites, contained herein or in our newsletters and blogs constitutes your agreement of same. MCMP did not receive any compensation for this article. However, officers, employees and affiliates may hold positions in the featured securities discussed in our newsletters or on our web site and blogs and may buy or sell said securities at any time without further notice. MCMP and/or affiliates may from time to time receive cash and/or equity compensation from featured companies for corporate communications services. In the interest of full disclosure, Mike Casson, MCMP’s Executive Editor and president of Casson Communications, LLC (CCLLC), an affiliated company, received twenty-five hundred dollars in cash compensation from OTC Stock Review for corporate communication services for the subject company. You should be aware of these potential conflicts of interest. We believe the information contained herein and in our publications to be reliable but cannot guarantee its accuracy; therefore, all information is provided as is without warranty of any kind. Past results are not necessarily indicative of future performance.

MicroCapMarketPlace.com

© 2022 MicroCap MarketPlace, All Rights Reserved